staar.com (STAA): Operating Profitability

STAAR Surgical Company (STAA) - corporate logo

The stability of STAAR Surgical Company (STAA) is confirmed by its resilience to Asian geopolitical risks, which, while tracking the core operating profit margin on GURU.Markets, we note via 6.70, serving as the current metric level. The operational base relies on a balance of the defensive healthcare sector with elective services and a strong R&D pipeline that eliminates any competency gaps. Such a foundation guarantees cost control and provides a margin of safety for the business.

STAA - STAAR Surgical Operating Profit Ratio over the range 07/04/2022 - 11/20/2026

STAA (STAAR Surgical): analytical breakdowns and indicator data

- share price and consensus valuation forecast:
- stock exchange capitalization data:
Fundamental valuation:STAAR Surgical Co., STAA
Core merchandise of staar.com

For STAAR Surgical Company (STAA), the operating profit margin on GURU.Markets reflects the production efficiency of implantable lenses. This metric is calculated as the ratio of operating profit to revenue, excluding the impact of taxes and debt obligations. The metric measures the business's ability to convert sales into profit before financial leverage. High margins confirm the scalability of the unique automation technology for miniature products. Steady growth in this indicator testifies to the fundamental stability and high profitability of the model.

Main competitors

ISRG (intuitive.com) - Operating Margin|Return on Sales by Operating Profit DHR (Danaher Corp.)|Operating Sales Margin BDX (Becton, Dickinson and Company)|Operating Profit Ratio STE|Operating Profitability West Pharma WST|Profitability of Operations Baxter (BAX)|MASI - Operating Profitability|Profitability of Operations Stevanato Group Corp STVN|TFX: Operating Margin|Operating Sales Margin Merit Medical Systems|Operating Profitability Envista Holdings Corp|Operating Sales Margin ICU Medical Corp (ICUI)|Operating Profitability DENTSPLY SIRONA Inc. (XRAY)|Operating Sales Margin LeMaitre LMAT|Operating Margin ATRC (atricure.com)|ChromaDex Corporation (NAGE) - Operating Return on Sales|ZimVie Inc - Operating Margin|Operating Return on Sales AngioDynamics|CERS (Cerus Corp) - Operating Sales Margin|Alpha Teknova, Inc. - Operating Profit Rate|MGRM (Monogram Orthopedics Inc.) - Operating Margin|STSS: Operating Profit Rate|Operating Sales Margin INFU (InfuSystem Holdings)|Utah Medical Products, Inc. - Return on Sales by Operating Profit|Operating Margin KRMD (korumedical.com)|Profitability of Operations Nyxoah, S.A. (NYXH)|MBOT - Operating Profitability|PDEX (Pro-Dex, Inc.) - Return on Sales by Operating Profit|ZTEK (Zentek Ltd) - Operating Sales Margin|ELUT - Profitability of Operations|MLSS (Milestone Scientific Corporation) - Operating Margin|Return on Sales by Operating Profit NXGL (NEXGEL, Inc.)|Operating Margin RVP|Operating Sales Margin Harvard Bioscience HBIO|Operating Margin FEMY (Femasys Corporation)|MHUA - Operating Sales Margin|POAI - Operating Profitability|Callan JMB (CJMB) - Operating Sales Margin|ATRI: Operating Margin|NURO - Profitability of Operations